ALNYLAM PHARMACE.DL-,0001 earnings per share and revenue

DUL earnings per share for the last quarter are -0.78 EUR whereas the estimation was -0.82 EUR which accounts for 5.09% surprise. Company revenue for the same period amounts to 449.90 M EUR despite the estimated figure of 478.63 M EUR. Estimated earnings per share for the next quarter are -0.55 EUR, and revenue is expected to reach 560.84 M EUR. Also watch annual changes over time to get a bigger picture of DUL earnings per share and revenue dynamics.